ArticleBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2024

Could a Long-Acting Prodrug of SN-38 be Efficacious in Sacituzumab Govitecan-Resistant Tumors?

Daniel V Santi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.